Sujit S Sansgiry

Dr. Sujit S Sansgiry

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Integrated Pharmacy Research and Practice
Verified
Journal Article
Open access
PDF file
SSSujit S Sansgiry
Sujit S Sansgiry
ABArchita H Bhansali
Archita H Bhansali
SBShweta S Bapat
Shweta S Bapat
QXQingqing Xu
Qingqing Xu
Self-care and self-medication practices are essential components of any health care systems. The use of over-the-counter (OTC) medications is a part of the self-medication process. The popularity of OTC medication use among patients may increase the abuse potential of OTC medications. With pharmacists being as accessible as they are, they are often the first line of contact for patients, and have the opportunity to educate and counsel patients on appropriate OTC medication use. The presence of a pharmacist ensures safe and effective use of OTC medications. Pharmacists can liaise with other health care providers in the management of self-care practices by patients. However, a pharmacist has traditionally been underutilized in this role. This article provides a brief review on OTC medications with abuse potential and the effect of self-medication on OTC medication abuse. This review further describes the barriers faced by pharmacists in OTC medication abuse management, given the increased potential of prescription-to-OTC switch in recent years. In addition, the potential for a behind-the-counter drug category to boost patient–pharmacist interaction was discussed. The current review supports the positive role played by pharmacists in the management of OTC medication abuse. This review adds to the knowledge base of the barriers faced by pharmacists to prevent OTC medication abuse while developing appropriate intervention strategies. By expanding the role of pharmacists, OTC medication abuse may be controlled more effectively, thereby providing better patient medication therapy management and outcomes.

1 September 2006 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
SSSujit S Sansgiry
Sujit S Sansgiry
MBMonali Bhosle
Monali Bhosle
KSKavita Sail
Kavita Sail
Objective. The objective of this study was to examine factors such as academic competence, test competence, time management, strategic studying, and test anxiety, and identify whether these factors...

16 June 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Oluwasola Stephen AyosanmiOluwasola Stephen Ayosanmi
Oluwasola Stephen Ayosanmi
BABabatunde Alli
Babatunde Alli
OAOluwatosin Adetolani Akingbule
Oluwatosin Adetolani Akingbule
AAAdeyemi Hakeem Alaga
Adeyemi Hakeem Alaga
JPJason Perpelkin
Jason Perpelkin
Jeff TaylorJeff Taylor
Jeff Taylor
It has been suggested that the COVID-19 pandemic led to an increase in self-medication practices across the world. Yet, there is no up-to-date synthesized evidence on the prevalence of self-medication that is attributable to the pandemic. This study aimed to conduct a systematic literature review on the prevalence and correlates of self-medication for the prevention and treatment of COVID-19 globally. The review was registered with the PROSPERO database. Searches were conducted following PRISMA guidelines, and relevant articles published between 1 April 2020 and 31 March 2022 were included. Pooled prevalence rate was conducted using the Meta package in R. A total of 14 studies from 14 countries, which represented 15,154 participants, were included. The prevalence of COVID-19-related self-medication ranged from 3.4–96%. The pooled prevalence of self-medication for this purpose was 44.9% (95% CI: 23.8%, 68.1%). Medications reported by studies for self-medication were antibiotics (79%), vitamins (64%), antimalarials (50%), herbal and natural products (50%), analgesics and antipyretics (43%), minerals and supplements (43%), cold and allergy preparations (29%), corticosteroids (14%), and antivirals (7%). The prevalence of self-medication with antibiotics is concerning. More public health education about responsible self-medication amidst the COVID-19 pandemic and future pandemics is required to mitigate the rising threat of antimicrobial resistance.

8 February 2017 in Community Mental Health Journal
Verified
Journal Article
Closed access
PDF file
YAYasser Almogbel
Yasser Almogbel
RGRohit Goyal
Rohit Goyal
SSSujit S Sansgiry
Sujit S Sansgiry

1 September 2006 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
SSSujit S Sansgiry
Sujit S Sansgiry
KSKavita Sail
Kavita Sail
Objectives. The objective of this study was to examine the association between student perceptions of course load, their ability to manage time, and test anxiety. Methods. A survey was self-adminis...

1 September 2015 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
SJSmruti Mpharm Jadav
Smruti Mpharm Jadav
SRSuja S. Rajan
Suja S. Rajan
SASusan Abughosh
Susan Abughosh
SSSujit S Sansgiry
Sujit S Sansgiry
Objectives: Considerable disparities in breast cancer screening exist between Hispanic and non-Hispanic white (NHW) women. Identifying and quantifying the factors contributing to these racial-ethnic disparities can help shape interventions and policies aimed at reducing these disparities. This study, for the first time, identified and quantified individual-level sociodemographic and health-related factors that contribute to racial-ethnic disparities in breast cancer screening using the nonlinear Blinder-Oaxaca decomposition method. Methods: Analysis of the retrospective pooled cross-sectional Medical Expenditure Panel Survey data from 2000 to 2010 was conducted. Women aged 40 years and older were included in the study. Logistic regressions were used to estimate racial-ethnic disparities in breast cancer screening. Nonlinear Blinder–Oaxaca decomposition method was used to identify and quantify the contribution of each individual-level factor toward racial-ethnic disparities. Results: Based on the unadjusted analyses, Hispanic women had lower odds of receiving mammogram screening (MS) (odds ratio [OR]: 0.74; 95% confidence interval [CI]: 0.69-0.80) and breast cancer screening (OR: 0.75; 95% CI: 0.70-0.81) as compared with NHW women. However, the relationship reversed in adjusted analyses, such that Hispanic women had higher odds of receiving MS (OR: 1.27; 95% CI: 1.16-1.40) and breast cancer screening (OR: 1.28; 95% CI: 1.17-1.40) as compared with NHW women. The Blinder-Oaxaca decomposition estimated that improving insurance status, access to care, education, and income will considerably increase screening rates among Hispanic women. Conclusions: The study projects that improving health care access and health education will considerably increase breast cancer screening compliance among Hispanic women. Policies like the Affordable Care Act, and patient navigation and health education interventions, might considerably reduce screening disparities in the Hispanic population.